Immunological significance of the accumulation of autophagy components in oral squamous cell carcinoma

Cancer Science

Volumn 106, Issue 1, 2015, Pages 1-8

  Sakakura, Koichi ^a   Takahashi, Hideyuki ^a   Kaira, Kyoichi ^a   Toyoda, Minoru ^a   Oyama, Tetsunari ^a   Chikamatsu, Kazuaki ^a  

^a GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Autophagy; Immune infiltrates; LC3; Oral squamous cell carcinoma; P62 SQSTM1

Indexed keywords

BECLIN 1; DOCETAXEL; GIMERACIL PLUS OTERACIL POTASSIUM PLUS TEGAFUR; HLA ANTIGEN CLASS 1; HLA ANTIGEN CLASS 2; LC3 PROTEIN; PROTEIN P62; TEGAFUR; TUMOR MARKER; TUMOR PROTEIN; UNCLASSIFIED DRUG; APOPTOSIS REGULATORY PROTEIN; BECN1 PROTEIN, HUMAN; LIGHT CHAIN 3, HUMAN; MEMBRANE PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SQSTM1 PROTEIN, HUMAN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; AUTOPHAGY; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELL INFILTRATION; CELL MOTILITY; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATIONAL STUDY; DENDRITIC CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOGENICITY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MOUTH SQUAMOUS CELL CARCINOMA; MULTIMODALITY CANCER THERAPY; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TUMOR IMMUNITY; TUMOR MICROENVIRONMENT; IMMUNOLOGY; KAPLAN MEIER METHOD; METABOLISM; MIDDLE AGED; MORTALITY; MOUTH TUMOR; MULTIVARIATE ANALYSIS; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; VERY ELDERLY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADULT; AGED; AGED, 80 AND OVER; APOPTOSIS REGULATORY PROTEINS; AUTOPHAGY; CARCINOMA, SQUAMOUS CELL; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; KILLER CELLS, NATURAL; MALE; MEMBRANE PROTEINS; MICROTUBULE-ASSOCIATED PROTEINS; MIDDLE AGED; MOUTH NEOPLASMS; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; T-LYMPHOCYTES;

EID: 84923257034     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/cas.12559     Document Type: Article

References (45)

1. Siegel R, Naishandham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin 2012; 62: 10-29.
2. Shah JP, Gil Z. Current concepts in management of oral cancer surgery. Oral Oncol 2009; 45: 394-401.
3. Bello IO, Soini Y, Salo T. Prognostic evaluation of oral tongue cancer: means, markers and prospectives (I). Oral Oncol 2010; 46: 630-5.
4. Mizushima N, Komatsu M. Autophagy: renovation of cells and tissues. Cell 2011; 147: 728-41.
5. Mathew R, Karp CM, Beaudoin B et al. Autophagy suppresses tumorigenesis through elimination of p62. Cell 2009; 137: 1062-75.
6. Degenhardt K, Mathew R, Beaudoin B et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51-64.
7. White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer 2012; 12: 401-10.
8. Mizushima N, Yamamoto A, Matsui M et al. In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. Mol Biol Cell 2004; 15: 1101-11.
9. Klionsky DJ, Cuervo AM, Seglen PO. Methods for monitoring autophagy from yeast to human. Autophagy 2007; 3: 181-206.
10. Mizushima N, Yoshimori T, Levine B. Methods in mammalian autophagy research. Cell 2010; 140: 313-26.
11. Liang XH, Jackson S, Seaman M et al. Induction of autophagy and inhibition of tumorigenesis by beclin 1. Nature 1999; 402: 672-6.
12. Pattingre S, Tassa A, Qu X et al. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 2005; 122: 927-39.
13. Zhou F, Yang Y, Xing D. Bcl-2 and Bcl-xL play important roles in the crosstalk between autophagy and apoptosis. FEBS J 2011; 278: 403-13.
14. Komatsu M, Waguri S, Koike M et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007; 131: 1149-63.
15. Komatsu M, Kageyama S, Ichimura Y. p62/SQSTM1/A170: physiology and pathology. Pharmacol Res 2012; 66: 457-62.
16. Li Y, Wang LX, Yang G et al. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res 2008; 68: 6889-95.
17. Li Y, Wang LX, Pang P et al. Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy. Clin Cancer Res 2011; 17: 7047-57.
18. Twitty CG, Jensen SM, Hu HM et al. Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism. Clin Cancer Res 2011; 17: 6467-81.
19. Michaud M, Martins I, Sukkurwala AQ et al. Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science 2011; 334: 1573-7.
20. Choi J, Jung W, Koo JS. Expression of autophagy-related markers beclin-1, light chain 3A, light chain 3B and p62 according to the molecular subtype of breast cancer. Histopathology 2013; 62: 275-86.
21. Miracco C, Cevenini G, Franchi A et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol 2010; 41: 503-12.
22. Reichert TE, Strauss L, Wagner EM et al. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma. Clin Cancer Res 2002; 8: 3137-45.
23. Garrido F, Cabrera T, Accolla RS et al. HLA and cancer. In: Charron D, ed. HLA, Vol. 1. Paris: EDK, 1997; 445-52.
24. Kaira K, Sunose Y, Arakawa K et al. Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. Br J Cancer 2012; 107: 632-8.
25. Buck AC, Schirrmeister HH, Guhlmann CA et al. Ki-67 immunostaining in pancreatic cancer and chronic active pancreatitis: does in vivo FDG uptake correlate with proliferative activity? J Nucl Med 2001; 42: 721-5.
26. Ladoire S, Chaba K, Martins I et al. Immunohistochemical detection of cytoplasmic LC3 puncta in human cancer specimens. Autophagy 2012; 8: 1175-84.
27. Ogino T, Bandoh N, Hayashi T et al. Association of tapasin and HLA class I antigen down-regulation in primary maxillary sinus squamous cell carcinoma lesions with reduced survival of patients. Clin Cancer Res 2003; 9: 4043-51.
28. Meissner M, Whiteside TL, van Kuik-Romein P et al. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation. Br J Dermatol 2008; 158: 930-40.
29. Baspinar S, Bircan S, Yavuz G et al. Beclin 1 and bcl-2 expressions in bladder urothelial tumors and their association with clinicopathological parameters. Pathol Res Pract 2013; 209: 418-23.
30. Guo GF, Jiang WQ, Zhang B et al. Autophagy-related proteins Beclin-1 and LC3 predict cetuximab efficacy in advanced colorectal cancer. World J Gastroenterol 2011; 17: 4779-86.
31. Fujii S, Mitsunaga S, Yamazaki M et al. Autophagy is activated in pancreatic cancer cells and correlates with poor patient outcome. Cancer Sci 2008; 99: 1813-9.
32. Tang JY, Hsi E, Huang YC et al. High LC3 expression correlates with poor survival in patients with oral squamous cell carcinoma. Hum Pathol 2013; 44: 2558-62.
33. Wang Y, Wang C, Tang H et al. Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma. J Oral Pathol Med 2013; 42: 557-64.
34. Huang L, Wang S, Li SS et al. Prognostic significance of Beclin-1 expression in laryngeal squamous cell carcinoma. Pathol Oncol Res 2013; 19: 771-7.
35. Jiang L, Huang S, Li W et al. Expression of autophagy and ER stress-related proteins in primary salivary adenoid cystic carcinoma. Pathol Res Pract 2012; 208: 635-41.
36. Chen Y, Li X, Wu X et al. Autophagy-related proteins LC3 and Beclin-1 impact the efficacy of chemoradiation on esophageal squamous cell carcinoma. Pathol Res Pract 2013; 209: 562-7.
37. Demachi-Okamura A, Torikai H, Akatsuka Y et al. Autophagy creates a CTL epitope that mimics tumor-associated antigens. PLoS ONE 2012; 7: e47126.
38. Ogino T, Shigyo H, Ishii H et al. HLA class I antigen down-regulation in primary laryngeal squamous cell carcinoma lesions as a poor prognostic marker. Cancer Res 2006; 66: 9281-9.
39. Tsuchikawa T, Ikeda H, Cho Y et al. Association of CD8+ T cell infiltration in oesophageal carcinoma lesions with human leucocyte antigen (HLA) class I antigen expression and survival. Clin Exp Immunol 2011; 164: 50-6.
40. Leffers N, Fehrmann RS, Gooden MJ et al. Identification of genes and pathways associated with cytotoxic T lymphocyte infiltration of serous ovarian cancer. Br J Cancer 2010; 103: 685-92.
41. Gaida MM, Welsch T, Herpel E et al. MHC class II expression in pancreatic tumors: a link to intratumoral inflammation. Virchows Arch 2012; 460: 47-60.
42. Mei Z, Liu Y, Liu C et al. Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer 2014; 110: 1595-605.
43. Jung AC, Guihard S, Krugell S et al. CD8-alpha T-cell infiltration in human papillomavirus-related oropharyngeal carcinoma correlates with improved patient prognosis. Int J Cancer 2013; 132: E26-36.
44. Albers AE, Ferris RL, Kim GG et al. Immune responses to p53 in patients with cancer: enrichment in tetramer+ p53 peptide-specific T cells and regulatory T cells at tumor sites. Cancer Immunol Immunother 2005; 54: 1072-81.
45. Strauss L, Bergmann C, Szczepanski M et al. A unique subset of CD4+ CD25highFoxp3+ T cells secreting interleukin-10 and transforming growth factor-beta1 mediates suppression in the tumor microenvironment. Clin Cancer Res 2007; 13: 4345-54.